Skip to Main Content
Head shot of Dr. Christopher Wolff

Dr. Christopher Wolff

Partner, Private Equity

christopherwolff@paulhastings.com

Dr. Christopher Wolff is a partner in the Corporate Department of Paul Hastings and co-chair of the firm’s Frankfurt office. He is a member of the Private Equity practice and concentrates on large cross-border transactions, especially private equity, usually involving complex capital structured financings.

Christopher has extensive transactional experience representing sellers and buyers in private equity, venture capital, M&A, distressed asset and corporate distressed restructuring transactions.

He studied law at the University of Constance, the University of Lausanne and Ludwig-Maximilians-University, Munich. He completed his first bar exam in 1996 and his second in 1998 at the same university. He completed his doctoral thesis on competition law in 2000 and is admitted to practice in Germany.

EDUCATION

Ernst-Moritz-Arndt-Universitat Greifswald, Dr. iur., 2000

Oberlandesgericht Muenchen, 2 St Exam, 1998

Ludwig Maximilian University of Munich, 1 St Exam, 1996

ADMISSIONS

Germany

Registered Foreign Lawyer (England & Wales)

LANGUAGE(S)

German

REPRESENTATIONS

  • Attestor Capital Ltd. in the acquisition (and its financing) of 51% of the shares in Condor Flugdienst GmbH and investment in the aggregate amount of € 200 million in Condor Flugdienst GmbH and envisaged conclusion of an equity leasing commitment in the aggregate amount of €250 million vis-à-vis Condor Flugdienst GmbH intended to be used for the renewal of their aircraft fleet.

  • Founders of Four 20 Pharma GmbH, one of the largest and fully EU-GMP and GDP licensed distributors of medical cannabis producers with a market share of over 10% in Germany in connection with the sale of a 55% stake in the company by to Curaleaf International Holdings Limited, Guernsey, the European holding company of the Canadian-listed Curaleaf Holdings Inc., a publicly traded cannabis provider.

RECOGNITIONS

  • “Dr. Christopher Wolff: very strong practice, very pleasant to deal with”, JUVE

  • “Dr. Christopher Wolff: always to the point, very good and solution-oriented negotiator (competitor).”, “often recommended, able also to work with unorthodox solutions, commercially oriented, experienced (competitor).”, JUVE

PUBLICATIONS

  • February 2018

ASSOCIATIONS

  • Lecturer

    Ruprecht-Karls-University, Heidelberg, post graduate studies LL.M. Corporate Restructuring Education

PAST ENGAGEMENTS

  • Participates in public panels on topics including recent changes of German insolvency- and corporate law